XML 27 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total BioLife Solutions,Inc.Shareholders’ Equity
Non-Controlling Interest Equity
Preferred Stock [Member]
Beginning Balance - Amount at Dec. 31, 2015 $ 9,859,371 $ 12,447 $ 72,823,398 $ (451) $ (64,326,923) $ 8,508,471 $ 1,350,900 $ 0
Beginning Balance - Shares at Dec. 31, 2015   12,448,391           0
Stock-based compensation 776,994   776,994     776,994    
Stock options/warrant exercises - Amount 246,280 $ 247 246,033     246,280    
Stock options/warrant exercises - Shares   246,164            
Stock Issued - on vested RSUs - Amount 0 $ 86 (86)     0    
Stock Issued - on vested RSUs - Shares   84,894            
Warrants Issued with Debt - WAVI 374,390   374,390     374,390    
Stock Issued for Services - Amount 135,000 $ 84 134,916     135,000    
Stock Issued for Services - Shares   84,375            
Other comprehensive income 451     451   451    
Elimination of remaining non-controlling interest equity on deconsolidation (184,974)           (184,974)  
Net loss (8,041,372)       (6,875,446) (6,875,446) (1,165,926)  
Ending Balance - Amount at Dec. 31, 2016 3,166,140 $ 12,864 74,355,645 0 (71,202,369) 3,166,140 0  
Ending Balance - Shares at Dec. 31, 2016   12,863,824            
Cumulative-effect adjustment resulting from adoption of ASU 2016-09 0   27,908   (27,908) 0    
Vesting of JV related stock-based compensation 22,317   22,317     22,317    
Series A preferred stock issued on conversion of related party note and accrued interest on June 30, 2017, net of stock issuance costs of $9,303 - Amount 4,240,697   4,240,693     4,240,697   $ 4
Series A preferred stock issued on conversion of related party note and accrued interest on June 30, 2017, net of stock issuance costs of $9,303 - Shares               4,250
Stock-based compensation 1,270,203   1,270,203     1,270,203    
Stock options/warrant exercises - Amount 3,978,336 $ 1,046 3,977,290     3,978,336    
Stock options/warrant exercises - Shares   1,045,719            
Stock Issued - on vested RSUs - Amount 0 $ 51 (51)     0    
Stock Issued - on vested RSUs - Shares   51,563            
Stock Issued for Services - Amount 142,499 $ 60 142,439     142,499    
Stock Issued for Services - Shares   60,316            
Preferred stock dividends (212,500)       (212,500) (212,500)    
Net loss (2,515,106)       (2,515,106) (2,515,106)    
Ending Balance - Amount at Dec. 31, 2017 $ 10,092,586 $ 14,021 $ 84,036,444 $ 0 $ (73,957,883) $ 10,092,586 $ 0 $ 4
Ending Balance - Shares at Dec. 31, 2017   14,021,422           4,250